| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 |
| A798417 | MACKLIN | Alverine Citrate | 10mM in DMSO | 720元/1ml; | 展开 |
|
| A864034 | MACKLIN | Alverine Citrate | 99% | 60元/1g; 252元/5g; 955元/25g; | 展开 |
|
| A2896 | TCI | Alverine Citrate | >95.0%(T)(HPLC) | 590元/1G; 1990元/5G; | 展开 |
基本信息 | 纯度/分析方法 | >95.0%(T)(HPLC) | | 分子式/分子量 | C20H27N・C6H8O7 = 473.57 | | 外观与形状(20℃) | 固体 | | 储存在惰性气体下 | 存放于惰性气体之中 | | 应避免的情况 | 空气 | | 包装和容器 | 1G-带有塑料内管的玻璃瓶 (查看图片) | | Reaxys-RN | 3851428 | | Merck Index (14) | 371 | | MDL编号 | MFCD00035086 |
技术规格 | Appearance | White to Almost white powder to crystal | | Purity(HPLC) | min. 95.0 area% | | Purity(Nonaqueous Titration) | min. 95.0 % | | Melting point | 100.0 to 104.0 ℃ |
物性(参考值) |
| 363724 | J&K | Alverine citrate salt | 98% | 621元/5G; 2049元/25G; | 展开 |
基本信息 | 分子式 | C26H35NO7 | | 分子量 | 473.56 | | MDL编码 | MFCD00035086 | | EINECS 编号 | 226-929-3 |
安全信息 |
| Y0000687 | | Alverine citrate salt | European Pharmacopoeia (EP) Reference Standard | 1861.35元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 应用 Used for studies of pharmacological activity including: - Synergism with fluconazole against Saccharomyces cerevisiae and Candida albicans
- Efficacy of combination with simeticone on abdominal pain associated with irritable bowel syndrome
- Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis
- Drug effects viewed from a signal transduction network perspective
- Enhanced cytotoxic effect of proteasome inhibitor MG132
- Mechanism of action on phasic smooth muscles
包装 Unit quantity: 5 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C20H27N · C6H8O7 | | 分子量 | 473.56 | | MDL编号 | MFCD00035086 | | PubChem化学物质编号 | 329831097 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | OC(=O)CC(O)(CC(O)=O)C(O)=O.CCN(CCCc1ccccc1)CCCc2ccccc2 | | InChI | 1S/C20H27N.C6H8O7/c1-2-21(17-9-15-19-11-5-3-6-12-19)18-10-16-20-13-7-4-8-14-20;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-8,11-14H,2,9-10,15-18H2,1H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12) | | InChI key | RYHCACJBKCOBTJ-UHFFFAOYSA-N | | Gene Information | human ... HNF4A(3172), HTR1A(3350) |
安全信息 | 储存分类代码 | 13 - Non Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP725 | | Alverine Citrate | British Pharmacopoeia (BP) Reference Standard | 2244.51元/100 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 应用 Used for studies of pharmacological activity including:
- Synergism with fluconazole against Saccharomyces cerevisiae and Candida albicans
- Efficacy of combination with simeticone on abdominal pain associated with irritable bowel syndrome
- Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis
- Drug effects viewed from a signal transduction network perspective
- Enhanced cytotoxic effect of proteasome inhibitor MG132
- Mechanism of action on phasic smooth muscles
包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C20H27N · C6H8O7 | | 分子量 | 473.56 | | MDL编号 | MFCD00035086 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | 格式 | neat | | SMILES string | OC(=O)CC(O)(CC(O)=O)C(O)=O.CCN(CCCc1ccccc1)CCCc2ccccc2 | | InChI | 1S/C20H27N.C6H8O7/c1-2-21(17-9-15-19-11-5-3-6-12-19)18-10-16-20-13-7-4-8-14-20;7-3(8)1-6(13,5(11)12)2-4(9)10/h3-8,11-14H,2,9-10,15-18H2,1H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12) | | InChI key | RYHCACJBKCOBTJ-UHFFFAOYSA-N | | Gene Information | human ... HNF4A(3172), HTR1A(3350) |
安全信息 | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
m.cnreagent.com